KPTI position history
The shares of Karyopharm Therapeutics (KPTI) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 51,000 shares, $375K, 0.09% of portfolio, New
- 2026 Q1: 45,800 shares, $255K, 0.06% of portfolio, Reduce −10.2%
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|